The North American biotechnology and life sciences sector continues to play a crucial role in advancing gene editing technologies. Growing investments in genomic research, precision medicine initiatives, and pharmaceutical innovation are supporting the increasing adoption of gene editing services across research institutions, biotechnology companies, and healthcare organizations. The region's...